View in EDS HTML Full Text PDF Full Text

Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report.

Saved in:
Bibliographic Details
Title: Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report.
Authors: Chu MQ; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China., Zhang TJ; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China.; Department of Oncology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China., Feng Y; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China., Shao X; Department of Nuclear Medicine, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China., Ji YH; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China., Qian J; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China., Zhou JD; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China.
Source: Frontiers in immunology [Front Immunol] 2025 Mar 31; Vol. 16, pp. 1566035. Date of Electronic Publication: 2025 Mar 31 (Print Publication: 2025).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40230856
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chu+MQ%22">Chu MQ</searchLink>; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Zhang+TJ%22">Zhang TJ</searchLink>; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China.; Department of Oncology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Feng+Y%22">Feng Y</searchLink>; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Shao+X%22">Shao X</searchLink>; Department of Nuclear Medicine, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Ji+YH%22">Ji YH</searchLink>; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Qian+J%22">Qian J</searchLink>; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Zhou+JD%22">Zhou JD</searchLink>; Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.; Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.; The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Mar 31; Vol. 16, pp. 1566035. <i>Date of Electronic Publication: </i>2025 Mar 31 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40230856
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1566035
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1566035
    Titles:
      – TitleFull: Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chu MQ
      – PersonEntity:
          Name:
            NameFull: Zhang TJ
      – PersonEntity:
          Name:
            NameFull: Feng Y
      – PersonEntity:
          Name:
            NameFull: Shao X
      – PersonEntity:
          Name:
            NameFull: Ji YH
      – PersonEntity:
          Name:
            NameFull: Qian J
      – PersonEntity:
          Name:
            NameFull: Zhou JD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 03
              Text: 2025 Mar 31
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1